Current Computer-Aided Drug Design

Journal Impact Factor: 1.6
Scopus Cite Score: 3.0
Aims and Scope:
Current Computer-Aided Drug Design (CCADD) is an interdisciplinary journal (or theme/initiative) dedicated to publishing high-quality research at the intersection of computational chemistry, artificial intelligence, and pharmaceutical sciences. The journal aims to accelerate drug discovery by integrating traditional computer-aided drug design (CADD) techniques with cutting-edge artificial intelligence-driven drug design (AIDD) methodologies. Topics of interest include, but are not limited to:
  1. AI/ML algorithms for hit identification, optimization, and target prediction
  2. Deep learning, generative models for de novo drug design
  3. Multi-omics integration, pharmacogenomics and AI for target identification
  4. AI-enhanced molecular dynamics and binding free energy calculations
  5. Structure- and ligand-based drug design
  6. AI-assisted repurposing of existing drugs and natural products

Current Computer-Aided Drug Design is an international, peer-reviewed journal in all aspects of drug design based on computational techniques, published bimonthly (print & online) by Bentham Science Publishers.
Read more...
Start Submission Button Icon

Editor-in-Chief:

  • Dong-Qing WeiState Key Laboratory of Microbial Metabolism and College of Life Sciences and Biotechnology
    Shanghai Jiaotong University
    Shanghai
    China

ISSN: 1573-4099 (Print)

eISSN: 1875-6697 (Online)

Special Issues With Active Call for Papers

Submission closes on: Oct 19, 2026
Recent Advances in Deep Learning and Machine Learning for Diabetic Retinopathy: Diagnosis, Prediction, and Personalized Screening

Diabetic retinopathy is a major cause of preventable blindness worldwide. Advances in deep learning and machine learning offer transformative tools for improving early detection, accurate diagnosis, and disease progression prediction. This special issue invites original research and comprehensive reviews that explore novel AI-driven methods for diabetic retinopathy screening, management, and personalized care. see more

Impact Factor: 1.6
Guest Editor(s): Dr. Abhishek Kumar
Co-Guest Editor(s): Dr. Sachin Ahuja,Dr. Vijay Pal Dhaka,Dr. Pramod Singh Rathore
Start Submission
Submission closes on: Aug 28, 2026
Explainable AI and Expert System Integration for Precision Drug Design

The rapid evolution of drug discovery demands intelligent frameworks that balance predictive accuracy, interpretability, and domain expertise. Traditional computational methods in drug design, such as molecular docking, QSAR modeling, and virtual screening, often struggle to capture the complex biological interactions underlying drug efficacy and toxicity. At the same time, modern machine learning and deep learning approaches, despite their remarkable performance, are frequently criticized for their “black-box” nature, which limits their acceptance in safety-critical domains such... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Sandeep Kumar Mathivanan
Co-Guest Editor(s): Dr. Saurav Mallik,Dr. Basu Dev Shivahare
Start Submission
Submission closes on: Aug 21, 2026
Computer-aided Endoscopy and Colonoscopy Diagnostics (CAD) for Medical Instruments: Data Insights for Prediction and Classification in Medical Imaging

The increasing prevalence of gastrointestinal diseases, particularly colorectal cancer, highlights the critical role of endoscopy and colonoscopy in early detection and diagnosis. These procedures rely on the ability to interpret real-time visual and diagnostic data accurately and efficiently. However, the growing complexity of medical imaging data, coupled with the need for timely decision-making, presents significant challenges for healthcare professionals. This special issue addresses these challenges by focusing on real-time data processing, predictive analytics, and machine... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Shabir Ahmad
Start Submission
Submission closes on: Mar 08, 2026
Computational Design of Plant-Based Therapeutics

Plant-based therapeutics have a long history of use in traditional medicine and are gaining renewed interest due to their potential for treating various diseases, including cancer, diabetes, and neurodegenerative disorders. However, the traditional approach to plant-based drug discovery is often time-consuming and resource-intensive. Computational methods offer a powerful and efficient approach to accelerate the discovery and development of plant-based therapeutics. By leveraging the power of computers, researchers can: • Reduce the time and cost associated... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Somdutt Mujwar
Start Submission
Submission closes on: Dec 31, 2025
Computer-Aided Drug Discoveries for Emerging Diseases

Computer-aided drug design is a rapidly growing research field that continues to gain momentum, attracting increasing interest from the scientific community. This trend is largely driven by the growing utilization of machine learning and artificial intelligence in drug design and discovery. Artificial Intelligence has proven efficacy across various applications, including the prediction of physical-chemical properties and biological activities of small molecules, in silico assessment of absorption, distribution, metabolism, and excretion and toxicological (ADMET) profiles of... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Sobia Ahsan Halim
Start Submission
Submission closes on: Dec 31, 2025
Artificial Intelligence in Biomedical Research: Enhancing Data Analysis for Drug Discovery and Development

This thematic issue highlights the transformative impact of Artificial Intelligence (AI), with a particular focus on Machine Learning (ML) and Deep Learning (DL) techniques, in advancing biomedical research. As a result of these cutting-edge AI methodologies, drug discovery and development are revolutionizing data analysis. Rapid advances in artificial intelligence technologies present unprecedented opportunities for accelerating drug discovery, optimizing therapeutic strategies, and enhancing treatment effectiveness. Researchers and clinicians can improve the precision and speed of identifying... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Fatma Latifoğlu
Co-Guest Editor(s): Prof. M. Murugappan,Dr. Şerife Benli,Dr. Muhammad Chowdhury
Start Submission
Submission closes on: Dec 31, 2025
Deep Learning Approaches in Bioinformatics for Computer-Aided Drug Development Targeting Brain Tumors

The integration of deep learning and bioinformatics is revolutionizing the field of computer-aided drug development, particularly in the fight against brain tumors one of the most aggressive and lethal types of cancer. Brain tumors present significant challenges due to their heterogeneity and complexity, which require novel approaches for early diagnosis and personalized treatment. By leveraging deep learning algorithms, researchers can extract valuable insights from vast and complex bioinformatics data, identifying novel therapeutic targets and accelerating... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Sandeep Kumar Mathivanan
Co-Guest Editor(s): Dr. Saurav Mallik,Dr. S.K.B. Sangeetha
Start Submission
Submission closes on: Dec 31, 2025
Emerging Trends in Computer-Aided Drug and Healthcare Solutions

This special issue aims to further the advancement of knowledge in drug design, healthcare innovations, and medical solutions by leveraging modern computational techniques. In recent years, computer-aided drug design has transformed the approach to medicinal chemistry, accelerating the drug discovery process and fostering innovation. The goal of this issue is to showcase pioneering research that highlights the application of computational methods, including molecular modeling, machine learning, deep learning, and bioinformatics, in the design and development... see more

Impact Factor: 1.6
Guest Editor(s): Dr. Prabhishek Singh
Co-Guest Editor(s): Dr. Manoj Diwakar
Start Submission